Stock Search
Search for you Ticker
Find and analyze stocks with comprehensive financial metrics including P/E ratios, dividend yields, and growth indicators. Filter by sector, valuation metrics, and performance to identify investment opportunities.
Company Overview
PFIZER INC
Health CarePharmaceuticalsPfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in N...
Pfizer Inc. ( FY-zər) is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. Founded in 1849 in New York by German entrepreneurs Charles Pfizer and Charles F. Erhart, Pfizer is one of the oldest pharmaceutical companies in North America.
Pfizer develops and produces medication and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company's largest products by sales are Eliquis (apixaban) ($7.9 billion in 2025 revenues, 13% of total revenues), Prevnar (a pneumococcal conjugate vaccine) ($6.5 billion in 2025 revenues, 10% of total revenues), Paxlovid (Nirmatrelvir/ritonavir) ($2.4 billion in 2025 revenues, 4% of total revenues), Vyndaqel (tafamidis) ($6.4 billion in 2025 revenues, 10% of total revenues), Comirnaty (the Pfizer–BioNTech COVID-19 vaccine) ($4.4 billion in 2025 revenues, 7% of total revenues), and Ibrance (palbociclib) ($4.1 billion in 2025 revenues, 7% of total revenues). In 2025, 59% of the company's revenues came from the United States, 5% came from China, and 36% came from other countries.
Exchange: NYSE
Company Statistics
Profile
Market Cap$170.12B
EV$225.05B
Shares Out5.7B
Revenue$63.70B
Margins
Gross73.2%
Operating51.6%
Pre-Tax6.6%
Net6.8%
FCF17.2%
Returns (5Yr Avg)
ROA7.6%
ROE17.6%
ROCE18.7%
ROIC34.6%
Valuation (TTM)
P/E39.3
P/B2.0
EV/Sales3.5
P/FCF15.5
EV/Gross Profit4.8
Financial Health
Cash$8.26B
Net Debt$54.94B
Debt/Equity0.7
EBIT/Interest12.2
Growth (CAGR)
Rev 3Yr-12%
Rev 5Yr8.5%
Dil EPS 3Yr-37.1%
Dil EPS 5Yr-3.6%
Dil EPS 10Yr2.1%
FCF 5Yr-5.7%
Shares 5Yr0.3%
Dividends
Yield5.8%
Payout2.3%
DPS$1.72
DPS Growth 3Yr-7.7%
DPS Growth 5Yr-3.7%
DPS Growth 10Yr1.3%
Price History
No price history available
Financial Performance
Display:
Data reported in USD
Assets vs Liabilities
Data reported in USD
Free Cash Flow
Data reported in USD